These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 8325951)
1. The effect of recombinant human growth hormone on regulation of growth hormone secretion and blood glucose in insulin-dependent diabetes. Wurzburger MI; Prelevic GM; Sönksen PH; Balint-Peric LA; Wheeler M J Clin Endocrinol Metab; 1993 Jul; 77(1):267-72. PubMed ID: 8325951 [TBL] [Abstract][Full Text] [Related]
2. Effect of recombinant human growth hormone treatment on insulin-like growth factor (IGF-I) levels in insulin-dependent diabetic patients. Wurzburger MI; Prelevic GM; Sönksen PH; Wheeler M; Balint-Peric L Acta Diabetol; 1995 Jun; 32(2):131-4. PubMed ID: 7579535 [TBL] [Abstract][Full Text] [Related]
3. Time-dependent reduction and potentiation of growth hormone (GH) responsiveness to GH-releasing factor induced by exogenous GH: role for somatostatin. Lanzi R; Tannenbaum GS Endocrinology; 1992 Apr; 130(4):1822-8. PubMed ID: 1347739 [TBL] [Abstract][Full Text] [Related]
4. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement. Span JP; Pieters GF; Sweep CG; Hermus AR; Smals AG J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049 [TBL] [Abstract][Full Text] [Related]
5. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans. Mauras N; Doi SQ; Shapiro JR J Clin Endocrinol Metab; 1996 Jun; 81(6):2222-6. PubMed ID: 8964855 [TBL] [Abstract][Full Text] [Related]
6. Time course and mechanism of growth hormone's negative feedback effect on its own spontaneous release. Lanzi R; Tannenbaum GS Endocrinology; 1992 Feb; 130(2):780-8. PubMed ID: 1346379 [TBL] [Abstract][Full Text] [Related]
7. The effect of the somatostatin analogue octreotide on growth hormone secretion in insulin-dependent diabetics without residual insulin secretion. Wurzburger MI; Prelevic GM; Sonksen PH; Balint-Peric LA Horm Metab Res; 1992 Jul; 24(7):329-32. PubMed ID: 1516889 [TBL] [Abstract][Full Text] [Related]
8. Gender differences in growth hormone response to exercise before and after rhGH administration and the effect of rhGH on the hormone profile of fit normal adults. Giannoulis MG; Boroujerdi MA; Powrie J; Dall R; Napoli R; Ehrnborg C; Pentecost C; Cittadini A; Jørgensen JO; Sonksen PH; Clin Endocrinol (Oxf); 2005 Mar; 62(3):315-22. PubMed ID: 15730413 [TBL] [Abstract][Full Text] [Related]
9. Systemic and splanchnic metabolic response to exogenous human growth hormone. Dahn MS; Lange MP Surgery; 1998 May; 123(5):528-38. PubMed ID: 9591005 [TBL] [Abstract][Full Text] [Related]
10. Regulation of growth hormone (GH) secretion by GH-releasing factor, somatostatin, and insulin-like growth factor I in ovine fetal and neonatal pituitary cells in vitro. Silverman BL; Bettendorf M; Kaplan SL; Grumbach MM; Miller WL Endocrinology; 1989 Jan; 124(1):84-9. PubMed ID: 2562828 [TBL] [Abstract][Full Text] [Related]
11. The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus. Bach MA; Chin E; Bondy CA J Clin Endocrinol Metab; 1994 Oct; 79(4):1040-5. PubMed ID: 7525624 [TBL] [Abstract][Full Text] [Related]
12. Serum growth hormone (GH)-binding protein and insulin-like growth factor-I levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol. Massa G; Bouillon R; Vanderschueren-Lodeweyckx M J Clin Endocrinol Metab; 1992 Nov; 75(5):1298-302. PubMed ID: 1430092 [TBL] [Abstract][Full Text] [Related]
13. Abuse of recombinant human growth hormone: studies in two different dog models. Rigamonti AE; Scanniffio D; Bonomo SM; Cella SG; Sartorio A; Müller EE Neuroendocrinology; 2004; 79(5):237-46. PubMed ID: 15218318 [TBL] [Abstract][Full Text] [Related]
14. The effect of polyethylene glycol recombinant human growth hormone on growth and glucose metabolism in hypophysectomized rats. Zhang ZX; Liu YK; Pan H; Pan L; Zhang Q; Su HM; Zhao QL; Li H; He C Growth Horm IGF Res; 2012 Feb; 22(1):30-5. PubMed ID: 22257554 [TBL] [Abstract][Full Text] [Related]
15. Differential long-term effects of insulin-like growth factor-I (IGF-I) growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats. Fielder PJ; Mortensen DL; Mallet P; Carlsson B; Baxter RC; Clark RG Endocrinology; 1996 May; 137(5):1913-20. PubMed ID: 8612531 [TBL] [Abstract][Full Text] [Related]
16. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans. Clemmons DR; Smith-Banks A; Underwood LE J Clin Endocrinol Metab; 1992 Jul; 75(1):234-8. PubMed ID: 1619015 [TBL] [Abstract][Full Text] [Related]
17. Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats. Böni-Schnetzler M; Hauri C; Zapf J Diabetologia; 1999 Feb; 42(2):160-6. PubMed ID: 10064095 [TBL] [Abstract][Full Text] [Related]
18. Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans. Mauras N; Horber FF; Haymond MW J Clin Endocrinol Metab; 1992 Nov; 75(5):1192-7. PubMed ID: 1430078 [TBL] [Abstract][Full Text] [Related]
19. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone. Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221 [TBL] [Abstract][Full Text] [Related]
20. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. Taaffe DR; Pruitt L; Reim J; Hintz RL; Butterfield G; Hoffman AR; Marcus R J Clin Endocrinol Metab; 1994 Nov; 79(5):1361-6. PubMed ID: 7525633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]